Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allowed)
National Institutes of Health
Tipo
Research/project funding
Posted on:
Funding Opportunity RFA-RM-24-007 from the NIH Guide for Grants and Contracts. The purpose of this Notice Of Funding Opportunity (NOFO) is to solicit applications on the optimization and characterization of technologies and assays with the potential for utilization and adoption in regulatory submissions of genome editing therapeutics.